Have you received the latest issue of the JDD? Below are Journal of Drugs in Dermatology highlights and editor picks for the October issue!
Consensus Recommendations on Adjunctive Topical Management of Atopic Dermatitis provides an overview of AD, summaries of pathophysiology and medical management, and discussion of epidermal barrier dysfunction and skin microbiome shifting associated with AD.
Emollient treatment may induce beneficial microbial changes in the mycobiome, and augment host-microbe balance in Effect of an Emollient on the Mycobiome of Atopic Dermatitis Patients
Epidemiology of Skin Diseases in a Diverse Patient Population examines the socioeconomic status of patients diagnosed with eczema or dermatitis.
Systemic Dapsone therapy demonstrates efficacy as a long-term non-immunosuppressive treatment for pyoderma gangrenosum ulcers in Efficacy of Systemic Dapsone Treatment for Pyoderma Gangrenosum: A Retrospective Review
Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Pooled Analysis of Phase 3 Clinical Trials presents results of pivotal clinical trials of ozenoxacin with the objective of evaluating the efficacy, safety, and tolerability of ozenoxacin 1% cream after twice-daily topical treatment for 5 days in patients with impetigo.
Safety and Efficacy of a Once-Daily Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled Trials investigates safety and efficacy in moderate-to-severe plaque psoriasis.
In patients who have failed apremilast, etanercept may represent an effective therapeutic option in Open-Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed Therapy With Apremilast.
Tretinoin 0.05% lotion provides greater efficacy than vehicle in Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older.
In Anatomic Site–Specific Treatment Response With 40% Hydrogen Peroxide (w/w) Topical Formulation for Raised Seborrheic Keratoses: Pooled Analysis of Data from Two Phase 3 Studies, investigators aimed to understand the relationship between SK location and clearance.
Treated patients with Fitzpatrick Skin Type V and VI experienced significant reductions in facial acne severity, lesion counts, and PIH severity/distribution in Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.
Biological Stability of Plasma Rich in Growth Factors-Derived Autologous Topical Serum After Three-Months Storage evaluates the stability of ATS derived from PRGF.
BoNTA may offer a novel therapeutic approach for preventing recurrent HSV disease in Decreased Labial Herpes Simplex Virus Outbreaks Following Botulinum Neurotoxin Type A Injection: A Case Report
Want to see past issue editor picks and highlights? Visit the JDD Corner on Next Steps in Derm!
Not a subscriber? Click here for information on how to receive your copy!
